Crohn's Disease Clinical Trials

• Diagnosis of Crohn's Disease (CD) for at least 3 months prior to screening

• Confirmed diagnosis of moderate-to-severe CD

• History of prior exposure to standard treatment (5-Amino Salicylates (5-ASAs), steroids, immunomodulators or antibiotics) or advanced therapies (ATs) (biologics or small molecules), but having inadequate response to, loss or response to or intolerance to at least one of these therapies

• On stable doses of standard treatments prior to screening (Oral 5-ASA compounds, Oral corticosteroids, Azathioprine (AZA), 6-Mercaptopurine (6-MP), or Methotrexate (MTX), or Antibiotics, etc.)

• Contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies